Trials / Active Not Recruiting
Active Not RecruitingNCT01722916
Reducing and Removing Hyaluronic Acid Filler With Hyaluronidase
Pilot Study of Appropriate Dosing for Reducing and Removing Hyaluronic Acid Filler With Hyaluronidase: A Randomized Control Clinical Trial
- Status
- Active Not Recruiting
- Phase
- EARLY_Phase 1
- Study type
- Interventional
- Enrollment
- 5 (estimated)
- Sponsor
- Northwestern University · Academic / Other
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to find how much hyaluronidase should be used when receiving injections of fillers.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Hyaluronidase |
Timeline
- Start date
- 2012-10-01
- Primary completion
- 2025-12-01
- Completion
- 2025-12-01
- First posted
- 2012-11-07
- Last updated
- 2025-01-31
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT01722916. Inclusion in this directory is not an endorsement.